Novel drug prevents common viral disease in stem-cell transplant patients … – EurekAlert (press release)
|
Novel drug prevents common viral disease in stem–cell transplant patients …
EurekAlert (press release) BOSTON — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital … Antiviral Protects Against CMV After Stem Cell TransplantsMedscape Novel Antiviral Blocks CMV After Stem Cell TxMedPage Today CMX001 reduced cytomegalovirus disease after HSCTHealio |
